Key Client Fiduciary Advisors, LLC - LEAP THERAPEUTICS INC ownership

LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 61 filers reported holding LEAP THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.

Quarter-by-quarter ownership
Key Client Fiduciary Advisors, LLC ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$522,177
-14.0%
1,535,816
+13.8%
0.33%
-20.5%
Q4 2022$607,194
-38.4%
1,349,321
+20.4%
0.41%
-54.0%
Q3 2022$986,000
-20.6%
1,120,943
+3.8%
0.89%
-26.3%
Q2 2022$1,242,000
-2.6%
1,080,101
+48.3%
1.21%
+20.2%
Q1 2022$1,275,000
-22.7%
728,230
+43.1%
1.01%
-26.1%
Q4 2021$1,649,000508,9801.36%
Other shareholders
LEAP THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
M28 Capital Management LP 2,664,400$2,345,0002.45%
Key Client Fiduciary Advisors, LLC 1,120,943$986,0000.89%
Knott David M Jr 900,000$792,0000.33%
ACT CAPITAL MANAGEMENT, LLC 265,000$233,0000.32%
Perceptive Advisors 7,472,148$6,575,0000.19%
Tri Locum Partners LP 711,798$626,0000.17%
683 Capital Management, LLC 2,265,000$1,993,0000.15%
Artal Group S.A. 4,000,000$3,520,0000.15%
TANG CAPITAL MANAGEMENT LLC 1,250,000$1,100,0000.14%
HealthCor Management, L.P. 1,066,689$939,0000.12%
View complete list of LEAP THERAPEUTICS INC shareholders